These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 26087796)

  • 21. [Helicobacter pylori eradication heals the duodenal ulcer. Randomized, simple, and controlled study with omeprazole].
    Piñero R; Pacheco M; Urrestarazu M; Serrano N; Olavarría R; Poleo JR
    G E N; 1995; 49(2):111-5. PubMed ID: 8566681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
    Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
    Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[Clinical Relevance Helicobacter Pylori Genotypes in Patients with Chronic Pancreatitis and Concomitant Infections Helicobacter Pylori].].
    Sarsenbaeva AS; Domracheva EV; Rustamov MN
    Eksp Klin Gastroenterol; 2016; (5):22-27. PubMed ID: 28614641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
    Avidan B; Melzer E; Keller N; Bar-Meir S
    Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
    Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
    Wong WM; Huang J; Xia HH; Fung FM; Tong TS; Cheung KL; Ho VY; Lai KC; Chan CK; Chan AO; Hui CK; Lam SK; Wong BC
    J Gastroenterol Hepatol; 2005 Jun; 20(6):935-40. PubMed ID: 15946144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
    McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
    N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
    Neuhann HF; Swai B; Carpenter CF; Shao O
    Trop Doct; 2003 Oct; 33(4):225-8. PubMed ID: 14620428
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 30. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
    Kang JM; Kim N; Lee DH; Park YS; Kim YR; Kim JS; Jung HC; Song IS
    Helicobacter; 2007 Dec; 12(6):623-8. PubMed ID: 18001404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
    Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
    J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
    Tucci A; Poli L; Gasperoni S; Varoli O; Paparo GF; De Giorgio R; Stanghellini V; Corinaldesi R
    Ital J Gastroenterol; 1994 Apr; 26(3):107-10. PubMed ID: 8061335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility.
    Cheon JH; Kim SG; Kim JM; Kim N; Lee DH; Kim JS; Jung HC; Song IS
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1590-5. PubMed ID: 16928222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
    Marko D; Calvet X; Ducons J; Guardiola J; Tito L; Bory F;
    Helicobacter; 2005 Feb; 10(1):22-32. PubMed ID: 15691312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What is the best first choice treatment option for Helicobacter pylori?
    Kadayifçi A
    Turk J Gastroenterol; 2007 Mar; 18(1):1-4. PubMed ID: 17450487
    [No Abstract]   [Full Text] [Related]  

  • 37. Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
    Nishizawa T; Maekawa T; Watanabe N; Harada N; Hosoda Y; Yoshinaga M; Yoshio T; Ohta H; Inoue S; Toyokawa T; Yamashita H; Saito H; Kuwai T; Katayama S; Masuda E; Miyabayashi H; Kimura T; Nishizawa Y; Takahashi M; Suzuki H
    J Clin Gastroenterol; 2015 Jul; 49(6):468-71. PubMed ID: 24921211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
    Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
    Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
    Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
    Sung JJ; Chung SC; Ling TK; Yung MY; Leung VK; Ng EK; Li MK; Cheng AF; Li AK
    N Engl J Med; 1995 Jan; 332(3):139-42. PubMed ID: 7800005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.